XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.2

License Agreements (Details Narrative) - USD ($)		1 Months Ended			6 Months Ended
	Apr. 04, 2023	Dec. 31, 2022	Jul. 31, 2022	Jan. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Accounts payable		$ 400,000			$ (351,830)	$ (35,716)
Gain on settlement for all liabilities	$ 626,223
Research and development expense				$ 100,000
Royalties percentage				10.00%
Acquired assets			$ 6,000,000		$ 508,607	$ 1,732,595
Turnkey Contract [Member]
Research and development expense			100,000
Deferred payment			300,000
Acquired assets			$ 354,000

X

- References

No definition available.

+ Details

Name:	aspi_RoyaltyPercentageOnSaleOfProducts
Namespace Prefix:	aspi_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The carrying amount of deferred costs.

+ References

No definition available.

+ Details

Name:	us-gaap_DeferredCostsCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

+ Details

Name:	us-gaap_IncreaseDecreaseInAccountsPayable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of other research and development expense.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482916/730-10-50-1

+ Details

Name:	us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

+ Details

Name:	us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aspi_TurnkeyContractMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: